The days of siloed approaches to chronic conditions such as HIV are over
In Conversation
We now have the scientific tools to end the HIV epidemic; the challenge lies in delivery
ISPOR sits at the nexus of science and policy, and we advocate that the best policies always rest on a foundation of good science
Astellas has steadily developed its immuno-oncology (IO) pipeline via both organic and inorganic means in recent years, with its early-phase IO projects now overseen by industry…
In 2023, we face a new digital relations landscape where a customer and a brand more and more rely on personal data exchange and unique communication…
There is trust in [Colombia], and regardless of which shade of government is in power, we will not stop investing in its future
Having a Latin American dimension, not only in the business but also in management, is a catalyst for sustainability
The pandemic has given us the opportunity to reclaim our spot in the APIs market and not repeat the mistakes of the past
Despite the projected GDP growth since 2020 in most of [LatAm], existing healthcare budgets and reforms are no longer adept at addressing the unmet needs, creating…
Our view is that all stakeholders – not just payers – have responsibility for ensuring access, meaning that building on strong collaborations and public-private partnerships will be…
Two LatAm countries – Colombia and Mexico – are [MSD's] top clinical trial patient enrollers worldwide, and LatAm makes up approximately 15 percent of our total…
Despite the uncertainty of [LatAm] markets - due to inflation, political issues or even social ones - these challenges are what make us stronger and perform…
